Benzodiazepine use in COPD: empirical evidence from Norway

Abstract

BACKGROUND The common comorbidities associated with COPD include, among others, anxiety, depression, and insomnia, for which the typical treatment involves the use of benzodiazepines (BZD). However, these medicines should be used with extra caution among COPD patients, since treatment with traditional BZD may compromise respiratory function. AIMS This… (More)
DOI: 10.2147/COPD.S83107

Topics

4 Figures and Tables

Cite this paper

@inproceedings{Halvorsen2015BenzodiazepineUI, title={Benzodiazepine use in COPD: empirical evidence from Norway}, author={Thomas Halvorsen and P{\aa}l Erling Martinussen}, booktitle={International journal of chronic obstructive pulmonary disease}, year={2015} }